Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers

Clinical trial NCT05735496 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05735496
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2023-03-09
Primary completion: 2025-07-21
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.